Sign in
IMA Stock Price, Chart, Stats & News
ImageneBio Inc
Save
65.87M
Market cap
–
Current P/E
–
Forward P/E
IMA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 0.71% |
ROA | -28.16% |
ROE | -33.97% |
D/E | 0.08x |
Interest coverage ratio | -569.19x |
IMA valuation
P/E | – |
P/S | – |
P/B | 0.42x |
P/CF | -1.17x |
P/FCF | -1.17x |
P/OCF | -1.17x |
PEG | 0.10x |
EV multiple | -1.61x |
About
ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Similar securities
Based on sector and market capitalization
Report issue